Current Ratio

Amicus Therapeutics currently has a Current Ratio of 2.84x, meaning its short-term assets (like cash and receivables) are 2.84 times its short-term liabilities, indicating a comfortable ability to cover near-term obligations.

This level is above the Healthcare sector median of 2.10x and places the company at the 57th percentile among sector peers, showing stronger liquidity than 57% of similar firms. Due to data limitations, both the year-over-year and quarter-over-quarter changes are listed as N/A, and no trend information is available for the last eight quarters. Without a trend, the analysis relies solely on the current level, which is above the median but not extremely high. The combination of a solid liquidity level with no directional data suggests the metric poses neither a clear opportunity nor an elevated risk. This neutral positioning aligns with the overall NEUTRAL verdict, as the Current Ratio does not contradict the assessment—it simply confirms a moderate, unremarkable financial position.

Frequently Asked Questions

Closest Sector Peers